PubMed Health⌕ Search

Biomedical subjects

H Bonnemain

Publications and source records attributed to H Bonnemain.

At least 19 recordsLinked to original sources

[Secret medicines].

Secret medicines had two characteristics: their formula remained unknown and they were prepared by many kinds of people. Before 1728 there were no general laws about these secret medicines but only peculiar rules. From 1728 to 1778, the King edicted rigorous rules in order to limit the number of secret medicines. Between 1778 and 1789, the law became more definite and the Royal Society of Medicine gave advices. The Law of Germinal An-XI forbid secret medicines but since 1805, some compromises took place. Slowly, secret medicines were replaced by pharmaceutics and new set of laws.

Drug and Narcotic Control↗

Interactions between genes involved in exocytotic membrane fusion in paramecium.

Crosses between members of two independent collections of Paramecium tetraurelia mutants blocked in the final membrane fusion step of trichocyst release (nd mutants) allowed us to define 13 complementation groups comprising 23 alleles. The mutant nd9a was then used as a target in a mutagenesis experiment designed to screen both revertants and new mutants in order to identify interacting genes. This mutant was chosen because it is the best known of its class to date and seems to be altered in assembly of the material connecting the trichocyst membrane to the plasma membrane and in assembly of the "rosette," a complex array of intramembranous particles in the plasma membrane at the trichocyst insertion sites. No revertants were obtained but two new mutants deficient for rosette assembly were identified, nd16b and nd18, whose gene products appear to interact with that of nd9. Indeed, the double mutants grown at 18 degrees, a permissive temperature for each of the single mutants, are characterized by a deficiency in exocytosis and in rosette assembly, as are also double mutants combining other allelic forms of the same genes. Moreover, aberrant dominance relationships among alleles of nd9 and of nd16 indicate the existence of interactions between identical subunits, which most likely assemble into multimeric structures. The nd16 gene product was shown by microinjection experiments to be a cytosolic factor, as is the nd9 gene product. It is therefore tempting to propose that the nd16 gene product also belongs to the connecting material and is involved in rosette assembly, in cooperation with nd9 and nd18.

Animals↗

Studies on synergistic toxic effects of copper and dithiocarbamate pesticides with the ciliate protozoan Colpidium campylum (Stokes).

The toxicity of seven dithiocarbamates and interactions occurring with copper were studied with the ciliate protozoan Colpidium campylum. No product was toxic at 0.1 mg liter-1. Thiram and mancozeb are the most toxic products (lethal at 1 mg liter-1) and ziram and propineb the least toxic. Concerning interactions with copper, no or slight interactions were observed with propineb and mancozeb, although a strong synergistic toxic effect was observed in a previous work with two structurally related products, maneb and zineb. On the contrary, the responses observed with alkyl-related dithiocarbamates (ferbam and ziram) and ethylene bis-related dithiocarbamates (nabam, thiram, and metiram) are in correlation with the results known in the literature. The synergistic toxic effect of copper and dithiocarbamates thus seems to be related mainly to the alkyl- or the ethylene bis-dithiocarbamate structure, but is not constant for molecules associated with metals (propineb, mancozeb, maneb, and zineb).

Animals↗

[Not Available].

Explore the source record for details and available documents.

France↗

[Not Available].

Explore the source record for details and available documents.

Belgium↗

[Not Available].

Explore the source record for details and available documents.

Economics, Medical↗

[Not Available].

Explore the source record for details and available documents.

France↗

[Not Available].

Explore the source record for details and available documents.

France↗

[Not Available].

Explore the source record for details and available documents.

Academies and Institutes↗

[Not Available].

Explore the source record for details and available documents.

France↗

[Not Available].

Explore the source record for details and available documents.

France↗

[Not Available].

Explore the source record for details and available documents.

France↗

[Not Available].

Explore the source record for details and available documents.

Education, Pharmacy↗

[Not Available].

Explore the source record for details and available documents.

France↗